Is Canopy Growth Corp. (TSX:WEED) Stock a Safe Buy?

Canopy Growth Corp. (TSX:WEED) (NYSE:CGC) is down from the 2018 highs. Is this the right time to own the stock?

Volatility continues to run wild in the marijuana stock industry and investors are trying to figure out which pot stocks are the safest bets heading into 2019.

Let’s take a look at Canopy Growth Corp. (TSX: WEED)(NYSE:CGC) to see if it deserves to be in your portfolio right now.

Volatile market

A year ago Canopy Growth traded for $18 per share. In the middle of October, it hit a closing high above $73 and has since given back a good chunk of the gains. At the time of writing, investors can buy the stock for $43 per share.

This is certainly not a stock for investors with a weak stomach, but in the sphere of marijuana companies, Canopy Growth is actually not that bad when it comes to big moves in the share price.

For example, Aphria just saw its stock tank 40% in two trading sessions due to a short-seller report that questioned the value of the company’s recent acquisition in Latin America.

Strong base

Canopy Growth is widely viewed as the name to beat in the sector, as the company’s management team appears to be making all the right moves. Canopy Growth acted early to buy rivals in an effort to get a leg up on the Canadian medical marijuana market and establish a foothold to prepare for the recently launched recreational market.

Canopy Growth was also the first Canadian cannabis producer to partner with a major beverage player. Constellation Brands, a U.S.-based wine, beer, and spirits company that owns Corona, bought a 9.9% stake in Canopy Growth last fall for $245 million.

The company invested an additional $5 billion in August to take its position to 38%. That deal was done at the equivalent of $48.60 per share, so Constellation is currently under water on the investment, but not by much given the strong pullback in the broader cannabis sector in recent weeks.

The two companies are working together to develop cannabis-infused beverages for the Canadian market once marijuana consumables are allowed for sale. That part of the market is expected to open sometime next near.

International focus

Canada gets most of the headlines, but Canopy Growth sees the largest opportunities in the growing global medical marijuana market. The company has an established presence in Europe through its German pharmaceutical distribution business and is building production facilities to supply patients in the region.

In Latin America, Canopy Growth has research and development operations in Chile and production assets in Colombia.

Should you buy?

The big investment from Constellation Brands appears to be a signal to the market that Canopy Growth is the real thing. The stock remains expensive based on its current revenue stream, and ongoing volatility should be expected.

However, Canopy Growth should be one of the companies that emerge as top global player once the market begins to mature. If you like the long-term potential for the marijuana industry, Canopy Growth is one name that deserves to be on your radar.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

tsx today
Stock Market

TSX Today: Why Canadian Stock Market Sell-off Could Intensify on Wednesday, November 18

The TSX could extend its losing streak at the open today as gold and silver prices tumble to their lowest…

Read more »

Stock Market

Copy of TSX Today: Why Canadian Stock Market Selloff Could Intensify on Wednesday, November 18

The TSX could extend its losing streak at the open today as gold and silver prices tumble to their lowest…

Read more »

oil pumps at sunset
Energy Stocks

This 6.2% Dividend Stock Brings Investors Money Every Month

This 6.2%-yielding TSX dividend stock recently raised its monthly payout again, backed by rising production, strong cash flow, and promising…

Read more »

dreaming of financial success
Dividend Stocks

Passive Income: Is Enbridge Stock Still a Buy for Its Dividend Yield?

Enbridge’s resilient cash flow profile, solid payout history, and a growing earnings base strengthen its appeal as a high yield…

Read more »

diversification and asset allocation are crucial investing concepts
Dividend Stocks

How Many Enbridge Shares You Need for $1,000 in Dividends

Enbridge pays $3.88 a share. At $68.59, you need 258 shares, about $17,696, to earn $1,000 a year in annual…

Read more »

space ship model takes off
Stocks for Beginners

Max Out Your TFSA Room With 2 Canadian Stocks Poised for Growth

These two Canadian growth stocks have strong fundamentals and promising expansion plans that could help TFSA investors build solid long-term…

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

3 AI Stocks Canadians May Like Better Than Nvidia

Nvidia's stock is down 32% amid controversies. Discover the implications for Nvidia and the chip industry amid these concerns.

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Stocks for Beginners

3 Best Growth Stocks in Canada for the Long Haul

These three Canadian growth stocks have strong business fundamentals and promising expansion opportunities that could help long-term investors build wealth.

Read more »